Potential of Aminoguanidine in Diabetic CAPD Patients

United States Renal Data System, USRDS 1994 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive Diseases, Bethesda, MD, September 1994.

Friedman E.A. Diabetic nephropathy is a hyperglycemic glomerulopathy. Arch Intern Med 1981; 142: 1269–70.

Makita Z. , Radoff S. , Rayfield E.J. Advanced glycosylation end products in patients with diabetic nephropathy. New Engl J Med 1991; 325: 836–42.

Ateshkadi A. , Johnson C.A. , Founds H.W. , Zimmerman S.W. Serum advanced glycosylation end-products in patients on hemodialysis and CAPD. Peril Dial Int 1995; (give volume and pages).

Papanastasiou P. , Grass L. , Rodela H. , Patrikarea A. , Oreopoulos D. , Diamandis E.P. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 1994; 46: 216–22.

Goldstein D.E. , Little R.R. , Wiedmeyer H.M. , England J.D. , Rohlfing C.L. , Wilke A.L. Is glycohemoglobin testing useful in diabetes mellitus? Lessons from the diabetes control and complications trial. Clin Chem 1994; 40: 1637–40.

Kilpatrick E.S. , Rumley A.G. , Dominiczak M.H. , Small M. Glycated hemoglobin values: problems in assessing blood glucose control in diabetes mellitus. Br Med J 1994; 309: 983–6.

Vlassara H. , Fuh H. , Makita Z. , Krungkrai S. , Cerami A. , Cucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A 1992; 89: 12043–7.

Brownlee M. Glycosylation of proteins and microangio pathy. Hosp Pract (Off Ed) 1992; 27(Suppl 1): 46–50.

Wautier J.L. , Wautier M.P. , Schmidt A.M. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994; 91: 7742–6.

Hasegawa G. , N akano K. , Tsutsumi Y. , Kondo M. Effects of aldehyde-modified proteins on mesangial cell-matrix interaction. Diabetes Res Clin Pract 1994; 23: 25–32.

Ellis E.N. , Good B.H. Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 1991; 40: 1016–19.

Hammes H.P. , Martin S. , Federlin K. , Geisen K. , Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991; 88: 11555–8.

Yagihashi S. , Kamijo M. , Baba M. , Yagihashi M. , Nagai K. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 1992; 41: 47–52.

Brownlee M. Pharmacological modulation of the advanced glycosylation reaction. Prog Clin Biol Res 1989; 304: 235–48.

Nicholls K. , Mandel T.E. Advanced glycosylation endproducts in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest 1989; 60: 486–91.

Corbett J.A. , Tilton R.G. , Chang K. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992; 4: 552–6.

Tilton R.G. , Chang K. , Hasan K.S. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42: 221–32.

Sensi M. , Pricci F. , Andreani D. , DiMario U. Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Res 1991; 16: 1–9.

Edelstein D. , Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 1992; 41: 26–9.

Eika B. , Levin R.M. , Longhurst P.A. Collagen and bladder function in streptozotocin-diabetic rats: effects of insulin and aminoguanidine. J Urol 1992; 148: 167–72.

Lamb E. , Venton T.R. , Cattell W.R. , Dawnay A. Serum glycated albumin and fructosamine in renal dialysis patients. Nephron 1993; 64: 82–8.

Lamb E. , Cat tell W.R. , Dawnay A. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis. Clin Sci 1993; 84: 619–26.